Interventional procedure overview of supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis
Closed for comments This consultation ended on at Request commenting lead permission
The evidence assessed
Rapid review of literature
The medical literature was searched to identify studies and reviews relevant to supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis. The following databases were searched, covering the period from their start to 28 June 2021: MEDLINE, PREMEDLINE, EMBASE, Cochrane Library and other databases. Trial registries and the Internet were also searched. No language restriction was applied to the searches (see the literature search strategy). Relevant published studies identified during consultation or resolution that are published after this date may also be considered for inclusion.
The inclusion criteria were applied to the abstracts identified by the literature search. Where selection criteria could not be determined from the abstracts the full paper was retrieved.
Characteristic | Criteria |
|---|---|
Publication type | Clinical studies were included. Emphasis was placed on identifying good quality studies. Abstracts were excluded where no clinical outcomes were reported, or where the paper was a review, editorial, or a laboratory or animal study. Conference abstracts were also excluded because of the difficulty of appraising study methodology, unless they reported specific adverse events that were not available in the published literature. |
Patient | |
Intervention/test | Supercapsular percutaneously assisted THA (SuperPath). |
Outcome | Articles were retrieved if the abstract contained information relevant to the safety and/or efficacy. |
Language | Non-English-language articles were excluded unless they were thought to add substantively to the English-language evidence base. |
List of studies included in the IP overview
This IP overview is based on 525 patients from 3 randomised controlled trials (Korytkin 2021; Meng 2021; Xie 2017), 2 non-randomised comparative studies (Rasuli 2015; Mas Martinez 2019) and 1 case series (Qultmann 2019). This overview also includes 3 implant summary reports for the Profemur L Modular Stem, Profemur L Classic Stem and Procotyl L Cup from the NJR (NJR 2020a, 2020b, 2020c).
Other studies that were considered to be relevant to the procedure but were not included in the main summary of the key evidence are listed in the appendix.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions